IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Enavate Sciences GP, LLC

Q1 2026 Holdings

Filed 2026-05-15 | 7 holdings | $351.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Sionna Therapeutics Inc(SION)COM829401108$99.3M2,478,03028.3%
Immunome Inc(IMNM)COM45257U108$79.0M3,613,79922.5%
Zenas Biopharma Inc(ZBIO)COM98937L105$76.6M3,919,15921.8%
Compass Therapeutics Inc(CMPX)COM20454B104$41.2M7,788,15011.7%
Bridgebio Oncology Therapeut(BBOT)COM NEW107924102$23.5M2,626,9466.7%
Upstream BIO Inc(UPB)COM91678A107$22.1M2,459,7036.3%
Camp4 Therapeutics Corp(CAMP)COM13463J101$9.7M2,190,9202.7%